주메뉴 바로가기
서브메뉴 바로가기
본문 바로가기
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15
R&D
Laboratory
Pipeline
Technology
IR
IR Resource
Public Disclosures
Public Disclosures
PR
Notice
News
Materials
Careers
Talents
Welfare
Recruitment
KOR
ENG
Goldmmune
TEL
menu open
VaxcellBio, Inc.
KOR
ENG
menu close
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15 for Companion Animals
R&D
Laboratory
Pipeline
Technology
IR
Public Disclosures
Careers
Talents
Welfare
Recruitment
ⓒ VaxCell Biotherapeutics Co., Ltd.
PR
Notice
News
Materials
News
•
홈
> PR >
News
뉴스(머니투데이방송) - 박셀바이오, 'Vax-NK', '박스루킨' 등 상표권 출원
관리자
2023. 05. 30. 09:31
ref.
2580
링크 :
https://news.mtn.co.kr/news-detail/2023052415161778176
Prev:
뉴스(이데일리) - 박셀바이오, NK치료제 간암 ‘치료목적 사용승인’
Next:
뉴스(매경헬스) - 박셀바이오, 中 혈액학회서 NK·CAR 치료제 연구결과 발표
List